Form 4: NHI CFO Exercises Options, Adjusts Holdings

Sentiment:

Insider Transaction Report


National Health Investors CFO John L. Spaid exercised stock options and sold shares for tax purposes, adjusting his direct beneficial ownership.

Summary

  • John L. Spaid, CFO/EVP Finance of National Health Investors Inc. (NHI), engaged in multiple transactions on January 16, 2026.
  • He exercised stock options to acquire a total of 32,000 shares of common stock.
  • These acquisitions were at exercise prices of $54.73 (8,500 shares), $57.76 (8,500 shares), and $73.34 (15,000 shares).
  • Concurrently, he disposed of 27,742 shares of common stock at a price of $80.43 per share, likely to cover taxes and exercise costs.
  • Following these transactions, Spaid's direct beneficial ownership of NHI common stock stands at 48,681.6372 shares.
  • The transactions were made pursuant to a Rule 10b5-1(c) plan.

Sentiment

Score: 6

Explanation: The CFO exercised a substantial number of options, reflecting a positive view when the options were granted. The subsequent sale of shares is a common practice for tax withholding and does not necessarily indicate a lack of confidence, but it does reduce the executive's direct stake. The transactions were pre-planned under a 10b5-1 plan.

Positives

  • CFO Spaid exercised a significant number of stock options (32,000 shares), indicating confidence in the company's long-term value at the time the options were granted.
  • The exercise prices ($54.73, $57.76, $73.34) are lower than the disposition price ($80.43), suggesting a profitable exercise for the insider.
  • The use of a Rule 10b5-1(c) plan indicates pre-planned transactions, reducing concerns about opportunistic trading based on non-public information.

Negatives

  • The disposition of 27,742 shares, even if for tax purposes, represents a reduction in direct beneficial ownership from the peak after option exercises.
  • The net effect of the transactions is a decrease in Spaid's total beneficial ownership from 76,423.6372 shares (after all exercises) to 48,681.6372 shares.

Future Outlook

NA

Industry Context

This filing is a routine insider transaction report and does not provide specific industry context. It reflects an individual executive's equity compensation activity within the healthcare REIT sector.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Insider Trading Policy AdherenceTransactions were made pursuant to a Rule 10b5-1(c) plan, demonstrating adherence to insider trading policies designed to prevent trading on material non-public information.01/16/2026Enhances transparency and reduces potential for insider trading concerns by pre-scheduling transactions.

Stakeholder Impact

  • Shareholders: Provides transparency into executive stock ownership and compensation activities. The net reduction in direct holdings might be viewed neutrally or slightly negatively, though the option exercise itself is a positive sign of past confidence.

Key Dates

DateDescription
02/23/2025Date exercisable for 8,500 stock options with an exercise price of $57.76.
02/24/2025Date exercisable for 8,500 stock options with an exercise price of $54.73.
03/03/2025Date exercisable for 15,000 stock options with an exercise price of $73.34.
01/16/2026Date of earliest transaction, involving option exercises and share disposition.
01/20/2026Signature date of the reporting person's representative.
02/24/2028Expiration date for 8,500 stock options with an exercise price of $54.73.
02/23/2029Expiration date for 8,500 stock options with an exercise price of $57.76.
03/03/2030Expiration date for 15,000 stock options with an exercise price of $73.34.

Recommendation

hold

This Form 4 filing details routine insider transactions by the CFO, involving the exercise of stock options and a subsequent sale of shares, likely for tax purposes, under a pre-arranged 10b5-1 plan. While the option exercise reflects past confidence, the net reduction in direct beneficial ownership is a neutral event. There is no new fundamental information about the company's operations, financial health, or strategic direction that would warrant a change in investment thesis based solely on this filing. Therefore, a 'hold' recommendation is appropriate as this filing does not provide a strong signal for buying or selling.

Keywords

National Health Investors, NHI, John L. Spaid, CFO, stock options, insider trading, Form 4, beneficial ownership, equity compensation, Rule 10b5-1

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.